- Home
- OPK vs ORIC Comparison
OPK vs ORIC Comparison
Compare OPK & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- ORIC
- Stock Information
- Founded
- OPK 2007
- ORIC 2014
- Country
- OPK United States
- ORIC United States
- Employees
- OPK N/A
- ORIC N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- OPK Health Care
- ORIC Health Care
- Exchange
- OPK Nasdaq
- ORIC Nasdaq
- Market Cap
- OPK 1.1B
- ORIC 1.1B
- IPO Year
- OPK 1995
- ORIC 2020
- Fundamental
- Price
- OPK $1.42
- ORIC $12.52
- Analyst Decision
- OPK Buy
- ORIC Strong Buy
- Analyst Count
- OPK 4
- ORIC 8
- Target Price
- OPK $2.28
- ORIC $16.57
- AVG Volume (30 Days)
- OPK 1.8M
- ORIC 1.4M
- Earning Date
- OPK 10-29-2025
- ORIC 11-06-2025
- Dividend Yield
- OPK N/A
- ORIC N/A
- EPS Growth
- OPK N/A
- ORIC N/A
- EPS
- OPK N/A
- ORIC N/A
- Revenue
- OPK $642,067,000.00
- ORIC N/A
- Revenue This Year
- OPK N/A
- ORIC N/A
- Revenue Next Year
- OPK $0.97
- ORIC N/A
- P/E Ratio
- OPK N/A
- ORIC N/A
- Revenue Growth
- OPK N/A
- ORIC N/A
- 52 Week Low
- OPK $1.11
- ORIC $3.90
- 52 Week High
- OPK $2.04
- ORIC $14.93
- Technical
- Relative Strength Index (RSI)
- OPK 40.81
- ORIC 50.19
- Support Level
- OPK $1.35
- ORIC $12.75
- Resistance Level
- OPK $1.50
- ORIC $13.57
- Average True Range (ATR)
- OPK 0.05
- ORIC 0.76
- MACD
- OPK -0.02
- ORIC -0.11
- Stochastic Oscillator
- OPK 23.81
- ORIC 38.63
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.